1. Home
  2. NUS vs IMRX Comparison

NUS vs IMRX Comparison

Compare NUS & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nu Skin Enterprises Inc.

NUS

Nu Skin Enterprises Inc.

HOLD

Current Price

$7.07

Market Cap

343.1M

Sector

Health Care

ML Signal

HOLD

Logo Immuneering Corporation

IMRX

Immuneering Corporation

HOLD

Current Price

$5.20

Market Cap

340.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NUS
IMRX
Founded
1984
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Other Pharmaceuticals
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
343.1M
340.7M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
NUS
IMRX
Price
$7.07
$5.20
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$17.20
AVG Volume (30 Days)
381.7K
771.7K
Earning Date
05-07-2026
05-04-2026
Dividend Yield
3.36%
N/A
EPS Growth
207.80
37.75
EPS
0.04
N/A
Revenue
$3,176,718,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$7.14
N/A
P/E Ratio
$2.22
N/A
Revenue Growth
48.98
N/A
52 Week Low
$6.99
$1.40
52 Week High
$14.62
$10.08

Technical Indicators

Market Signals
Indicator
NUS
IMRX
Relative Strength Index (RSI) 40.45 44.61
Support Level $7.03 $4.83
Resistance Level $8.08 $5.36
Average True Range (ATR) 0.28 0.33
MACD -0.03 -0.06
Stochastic Oscillator 46.79 13.79

Price Performance

Historical Comparison
NUS
IMRX

About NUS Nu Skin Enterprises Inc.

Nu Skin Enterprises Inc develops and distributes a comprehensive line of beauty and wellness solutions in various countries. The company operates in two primary product categories: beauty and wellness products. Additionally, the company also operates through its subsidiary, Rhyz. It reports revenue from nine segments, consisting of its seven geographic Nu Skin segments: Americas, Southeast Asia/Pacific, Mainland China, Japan, Europe & Africa, South Korea, and Hong Kong/Taiwan and two Rhyz segments: manufacturing, which includes manufacturing and packaging subsidiaries it has acquired; and Rhyz Other, which includes other investments by its Rhyz strategic investment arm. The majority of the company's revenue is generated from the Wellness product category from the Americas segment.

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

Share on Social Networks: